BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27766602)

  • 1. Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases.
    Polansky H; Itzkovitz E; Javaherian A
    Clin Transl Med; 2016 Dec; 5(1):40. PubMed ID: 27766602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir.
    Polansky H; Javaherian A; Itzkovitz E
    Drug Des Devel Ther; 2016; 10():2713-22. PubMed ID: 27621592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes.
    Polansky H; Javaherian A; Itzkovitz E
    J Evid Based Integr Med; 2018; 23():2515690X18806269. PubMed ID: 30362389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus.
    Polansky H; Itzkovitz E; Javaherian A
    Drug Des Devel Ther; 2017; 11():575-583. PubMed ID: 28424535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases.
    Polansky H; Itzkovitz E; Javaherian A
    Clin Transl Med; 2019 Feb; 8(1):5. PubMed ID: 30725243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
    Fife KH; Almekinder J; Ofner S
    Sex Transm Dis; 2007 May; 34(5):297-301. PubMed ID: 16960547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir in the treatment of genital herpes and herpes zoster.
    Baker DA
    Expert Opin Pharmacother; 2002 Jan; 3(1):51-8. PubMed ID: 11772333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of genital herpes.
    Mertz GJ
    Adv Exp Med Biol; 1996; 394():1-10. PubMed ID: 8815676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.
    Romanowski B; Marina RB; Roberts JN;
    Sex Transm Dis; 2003 Mar; 30(3):226-31. PubMed ID: 12616141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of perinatal herpes: prophylactic antiviral therapy?
    Scott LL
    Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Melatonin Alone or Associated with Acyclovir on the Suppressive Treatment of Recurrent Genital Herpes: A Prospective, Randomized, and Double-Blind Study.
    Roa CL; Cipolla-Neto J; Reiter RJ; Linhares IM; Lepique AP; de Aguiar LM; Seganfredo IB; Ferreira-Filho ES; de Medeiros SF; Baracat EC; Soares-JĂșnior JM
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
    Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
    J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
    Gupta R; Wald A
    Expert Opin Pharmacother; 2006 Apr; 7(6):665-75. PubMed ID: 16556084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.